Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
First set out in a scientific paper last September, Pathway’s post-transformer architecture, BDH (Dragon hatchling), gives LLMs native reasoning powers with intrinsic memory mechanisms that support ...
env zero, a leader in Infrastructure as Code (IaC) management and governance, and CloudQuery, a leading cloud asset management platform, announced the successful close of their merger—with the ...
Non-model organisms are organisms that have not been selected by the research community for extensive study either for historic reasons, or because they lack the features that make model organisms ...
This profile has not been claimed by the company. See reviews below to learn more or submit your own review. John Casablancas International provides modeling and acting training programs. Founded in ...